Latest Stock Split Details
Key information about AroCell AB (publ)'s most recent stock split
Split Date: 2022-01-25
Split Ratio: 509:500
Price Before Split: $0.82
Price After Split: $0.81
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.02 times more shares (a 509:500 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of AroCell AB (publ)'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2022-01-25 | 509:500 | No | $0.82 | $0.81 |
| 2019-11-14 | 507:500 | No | $1.55 | $1.53 |
| 2014-09-03 | 1041:1000 | No | $6.51 | $6.25 |
| 2013-05-15 | 1089:1000 | No | $3.60 | $3.31 |
| 2012-03-15 | 117:100 | No | $2.70 | $2.31 |
About AroCell AB (publ)
Company overview and industry information
AroCell AB (publ) (AROC.ST) operates in the Medical - Diagnostics & Research industry. The recent 509-for-500 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Medical - Diagnostics & Research
Go to AroCell AB (publ) Summary